What is LENSAR Inc (LNSR) stock price today?

LENSAR Inc (LNSR) currently trades at $5.23 per share. The stock has a market capitalization of $63.02M and a P/E ratio of —x.

Is LNSR stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, LENSAR Inc has a Smart Value Score of 26/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is LENSAR Inc's revenue and earnings?

LENSAR Inc has trailing twelve-month (TTM) revenue of $58.44M with profit margins of -58.70%. Earnings per share (EPS) is $-2.87.

Is LNSR stock overvalued or undervalued?

Based on our DCF model, LENSAR Inc's intrinsic value is $13.10, representing a margin of safety of 5.19%. The stock currently trades at a P/E of —x.

LNSR

LENSAR Inc

NASDAQ: LNSR · HEALTHCARE · MEDICAL DEVICES

$5.23

-2.97% today

Updated 2026-04-30

Market cap

$63.02M

P/E ratio

—

P/S ratio

1.08x

EPS (TTM)

$-2.87

Dividend yield

—

52W range

$5 – $14

Volume

0.1M

Market cap

$63.02M

P/E ratio

—

P/S ratio

1.08x

EPS (TTM)

$-2.87

Dividend yield

—

52W range

$5 – $14

Volume

0.1M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.7

Growth

5.0

Quality

C+

2.0

Profitability

5.3

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$8.50

+62.52%

12-Month target

—

Intrinsic (DCF)

$13.10

Margin of safety

+5.19%

0 Strong Buy1 Buy1 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Free cash flow $618000.00 — positive

Risks

- Thin margins at -58.70%

- Revenue declining -4.20% QoQ

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$35.36M	$42.16M	$53.49M	$58.44M	$58.44M
Net income	$-19.91M	$-14.38M	$-31.40M	$-34.28M	$-1.46M
EPS	—	—	—	—	$-2.87
Free cash flow	$-14.97M	$-9.89M	$-2.43M	$-14.91M	$618000.00
Profit margin	-56.32%	-34.11%	-58.71%	-58.66%	-58.70%

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
LNSR	$63.02M	26	4.7	2.0	5.3	5.0	+5.19%	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

LENSAR Inc trades at $5.23. Our Smart Value Score of 26/100 indicates the stock is weak. TTM revenue stands at $58.44M. with profit margins at -58.70%. Our DCF model estimates intrinsic value at $13.10.

Frequently asked questions

What is LENSAR Inc's stock price?

LENSAR Inc (LNSR) trades at $5.23.

Is LENSAR Inc overvalued?

Smart Value Score 26/100 (Grade F, Strong Sell). DCF value $13.10.

What is the price target of LENSAR Inc (LNSR)?

The analyst target price is $8.50, representing +62.5% upside from the current price of $5.23.

What is the intrinsic value of LENSAR Inc (LNSR)?

Based on our DCF model, intrinsic value is $13.10, a +5.2% margin of safety versus $5.23.

What is LENSAR Inc's revenue?

TTM revenue is $58.44M.

Company info

SectorHEALTHCARE

IndustryMEDICAL DEVICES

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio1.08x

ROE-1,069.00%

Beta0.99

50D MA$8.27

200D MA$11.08

Shares out0.01B

Float0.01B

Short ratio—

Avg volume0.1M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

LNSR vs LLY →LNSR vs JNJ →LNSR vs ABBV →Stock screener →